Management of anxiety and depression in patients with COPD

2.50
Hdl Handle:
http://hdl.handle.net/2173/35992
Title:
Management of anxiety and depression in patients with COPD
Authors:
Yohannes, Abebaw M.
Citation:
Expert review of respiratory medicine, 2008, vol. 2, no. 3, pp. 337-347
Publisher:
Expert Reviews
Issue Date:
Jun-2008
URI:
http://hdl.handle.net/2173/35992
DOI:
10.1586/17476348.2.3.337
Additional Links:
http://www.future-drugs.com/page/journal/ers/teaser
Abstract:
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and disability in the elderly. The two common psychiatric conditions in COPD patients are anxiety and depression. This article reviews the level of evidence available on the management of anxiety and depression in patients with COPD. Depression and anxiety are associated with a greater level of physical disability, impaired quality of life, increased usage of healthcare services, noncompliance with medical treatment and elevated risk of mortality. The findings of the available literature suggest that antidepressant drug therapy, pulmonary rehabilitation, cognitive behavioral therapy, education and self-management are inconclusive in the treatment of anxiety and depression. This review also highlights our current understanding of the etiology of anxiety and depression, and assessment tools and implications for treatment. The collaborative care model (CCM) has been shown to be beneficial in the treatment of depression and acceptable for older patients in primary-care settings. It is worth investigating the benefits of CCM in patients with COPD. Healthcare providers should invest more time and resources into staff training to overcome barriers in the detection and treatment of depression and anxiety in order to improve the quality of life and survival in patients with COPD. Expected future considerations and developments in this field are also discussed.
Type:
Article
Language:
en
Description:
Full-text of this article is not available in this e-prints service. This article was originally published in Expert reviews in respiratory medicine, published by and copyright Expert Reviews.
Keywords:
Anxiety; Chronic obstructive pulmonary disease; Depression; Management; Mood; Quality of life; Treatment
ISSN:
1747-6348
EISSN:
1747-6356

Full metadata record

DC FieldValue Language
dc.contributor.authorYohannes, Abebaw M.-
dc.date.accessioned2008-08-20T13:27:49Z-
dc.date.available2008-08-20T13:27:49Z-
dc.date.issued2008-06-
dc.identifier.citationExpert review of respiratory medicine, 2008, vol. 2, no. 3, pp. 337-347en
dc.identifier.issn1747-6348-
dc.identifier.doi10.1586/17476348.2.3.337-
dc.identifier.urihttp://hdl.handle.net/2173/35992-
dc.descriptionFull-text of this article is not available in this e-prints service. This article was originally published in Expert reviews in respiratory medicine, published by and copyright Expert Reviews.en
dc.description.abstractChronic obstructive pulmonary disease (COPD) is a major cause of morbidity and disability in the elderly. The two common psychiatric conditions in COPD patients are anxiety and depression. This article reviews the level of evidence available on the management of anxiety and depression in patients with COPD. Depression and anxiety are associated with a greater level of physical disability, impaired quality of life, increased usage of healthcare services, noncompliance with medical treatment and elevated risk of mortality. The findings of the available literature suggest that antidepressant drug therapy, pulmonary rehabilitation, cognitive behavioral therapy, education and self-management are inconclusive in the treatment of anxiety and depression. This review also highlights our current understanding of the etiology of anxiety and depression, and assessment tools and implications for treatment. The collaborative care model (CCM) has been shown to be beneficial in the treatment of depression and acceptable for older patients in primary-care settings. It is worth investigating the benefits of CCM in patients with COPD. Healthcare providers should invest more time and resources into staff training to overcome barriers in the detection and treatment of depression and anxiety in order to improve the quality of life and survival in patients with COPD. Expected future considerations and developments in this field are also discussed.en
dc.language.isoenen
dc.publisherExpert Reviewsen
dc.relation.urlhttp://www.future-drugs.com/page/journal/ers/teaseren
dc.subjectAnxietyen
dc.subjectChronic obstructive pulmonary diseaseen
dc.subjectDepressionen
dc.subjectManagementen
dc.subjectMooden
dc.subjectQuality of lifeen
dc.subjectTreatmenten
dc.titleManagement of anxiety and depression in patients with COPDen
dc.typeArticleen
dc.identifier.eissn1747-6356-
All Items in e-space are protected by copyright, with all rights reserved, unless otherwise indicated.